Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuwellis Inc (NUWE) vs State Street PDR S&P Retail ETF (XRT) Price & Performance

Nuwellis IncTrade
State Street PDR S&P Retail ETFTrade

Price performance (Past 24H)

Key statistics

Nuwellis Inc vs State Street PDR S&P Retail ETF — how do they compare? Nuwellis Inc trades at $0.69 (market cap $2.20M), while State Street PDR S&P Retail ETF trades at $86.52 (market cap $389.66M). The key difference: State Street PDR S&P Retail ETF is far larger — about 177.1× Nuwellis Inc's market cap, and State Street PDR S&P Retail ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and State Street PDR S&P Retail ETF for 44 Days on average.

NUWEXRT
Market Cap
$2.20M$389.66M
Volume
121,5444,275,820
Sector
HealthBroad Market / Factor
52-Week High
$146.65$92.35
52-Week Low
$0.68$77.28
Typical Hold Time
26 Days44 Days
Enterprise Value
-$1.52M—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

State Street PDR S&P Retail ETF

XRT (SPDR S&P Retail ETF) trades at $82.91, showing minimal daily movement with a slight decline of 0.05%. Technical indicators signal a bearish trend overall, with moving averages particularly negative. The ETF faces headwinds from higher interest rates and inflation impacting consumer spending, though recent retail sales data showed a strong August rebound. Analyst sentiment remains cautious with expectations of continued underperformance against broader market indices.

The retail sector faces macroeconomic pressures including inflation and rising rates that weigh on consumer discretionary spending. While holiday sales projections exceed $1 trillion, selective consumer behavior favors value-oriented retailers. Near-term performance depends on Fed policy direction and consumer resilience during the critical holiday season, with technical resistance at $83-$84 levels limiting upside potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUWE
40% Buy60% Sell
Avg holding period · 26 Days
XRT

No sentiment data available yet.

Top news

Latest headlines on both assets

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →

About State Street PDR S&P Retail ETF

XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.

Read more on XRT →